1. Home
  2. ASPN vs IMCR Comparison

ASPN vs IMCR Comparison

Compare ASPN & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

HOLD

Current Price

$2.94

Market Cap

573.2M

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$36.36

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPN
IMCR
Founded
2001
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
573.2M
1.7B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
ASPN
IMCR
Price
$2.94
$36.36
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$13.00
$67.00
AVG Volume (30 Days)
1.6M
276.8K
Earning Date
02-11-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$352,852,000.00
$379,590,000.00
Revenue This Year
N/A
$32.31
Revenue Next Year
N/A
$10.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
28.11
52 Week Low
$2.86
$23.15
52 Week High
$14.30
$40.72

Technical Indicators

Market Signals
Indicator
ASPN
IMCR
Relative Strength Index (RSI) 31.87 49.55
Support Level $2.86 $35.41
Resistance Level $3.08 $37.25
Average True Range (ATR) 0.16 1.58
MACD 0.08 -0.16
Stochastic Oscillator 15.49 26.41

Price Performance

Historical Comparison
ASPN
IMCR

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: